Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **dura mater of the spinal cord** is the thick, tough, fibrous outermost membrane covering the spinal cord, comprising a single meningeal layer that forms the so-called spinal dural sac or thecal sac[1][3][6]. Unlike the cranial dura mater, which has two layers, the spinal dura mater consists only of the meningeal layer[1][3]. This membrane protects, anchors, and supports the spinal cord, forming a barrier around the central nervous system and providing an enclosure for the cerebrospinal fluid (CSF) within the subarachnoid space[1][3][5][6]. The spinal dura is not a molecular or therapeutic target in the sense of receptors, enzymes, or transporters, but rather a structural tissue that plays a critical role in neurosurgical and anesthetic procedures (e.g., spinal taps, epidural anesthesia) and may be involved in disease processes such as meningitis or spinal hematomas[3][6]. Additional notes: - As “Dura mater of spinal cord” refers to a protective tissue and not a molecular entity, receptor, or enzyme, it is not appropriate to classify it as a drug target. - Commonly encountered in anatomical and clinical contexts, but “Dura mater of spinal cord” is not a conventional or canonical name for a druggable target and does not have a widely accepted abbreviation. - Some information fields above (“interacting_drugs,” “mechanism_of_action,” “biomarkers”) are not applicable for an anatomic tissue.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dura mater of spinal cord.